{"product_id":"george-washington-university-infectious-disease-board-review-course-2025-lecture-qbank","title":"George Washington University Infectious Disease Board Review Course 2025 (Lecture + QBank)","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: infectious disease fellows, physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eWhat You Will Learn\u003c\/p\u003e\n\u003cp\u003eCore concepts and high-impact updates across the field of infectious diseases, including antimicrobial therapy, HIV\/AIDS management, tropical medicine, endocarditis, opportunistic infections, and infection control\u003c\/p\u003e\n\u003cp\u003eEffective strategies and diagnostic frameworks for challenging syndromes—such as sepsis, fever of unknown origin, transplant-associated infections, and antimicrobial resistance\u003c\/p\u003e\n\u003cp\u003eEvidence-based best practices and guidelines for patient-centered care in both inpatient and outpatient settings\u003c\/p\u003e\n\u003cp\u003eTargeted board preparation with reinforced explanations through realistic, case-based multiple-choice questions\u003c\/p\u003e\n\u003cp\u003eEvent Details\u003c\/p\u003e\n\u003cp\u003eFormat: Fully on-demand online delivery combining expert video lectures with a robust, interactive question bank\u003c\/p\u003e\n\u003cp\u003eComponents: Includes high-yield lecture modules, a question bank with detailed explanations, and downloadable study materials tailored to infectious disease board content\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003eWhy Attend\u003c\/p\u003e\n\u003cp\u003eThis course is your most efficient and effective path to board success—combining comprehensive content, active learning, and flexible delivery.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eDay 1 – Core Concepts \u0026amp; Immunocompromised Hosts\u003c\/p\u003e\n\u003cp\u003eIntroduction \u0026amp; overview\u003c\/p\u003e\n\u003cp\u003eMicrobiology essentials for the exam\u003c\/p\u003e\n\u003cp\u003ePrinciples of antimicrobial therapy: toxicities, PK\/PD, drug–drug interactions\u003c\/p\u003e\n\u003cp\u003eAntibacterial drugs I – approach to resistant gram-negative bacilli\u003c\/p\u003e\n\u003cp\u003eAntiviral drugs\u003c\/p\u003e\n\u003cp\u003eRespiratory viral infections including influenza (immunocompetent \u0026amp; immunocompromised)\u003c\/p\u003e\n\u003cp\u003eImmunizations: domestic, travel, occupational\u003c\/p\u003e\n\u003cp\u003eInfections in hematopoietic stem cell recipients\u003c\/p\u003e\n\u003cp\u003eInfections in the neutropenic cancer patient\u003c\/p\u003e\n\u003cp\u003eDay 2 – Hepatitis, GI \u0026amp; Parasitic Infections\u003c\/p\u003e\n\u003cp\u003eAcute hepatitis\u003c\/p\u003e\n\u003cp\u003eChronic hepatitis\u003c\/p\u003e\n\u003cp\u003eClinical immunology \u0026amp; host defense\u003c\/p\u003e\n\u003cp\u003eCMV, EBV, HHV6, HHV8\u003c\/p\u003e\n\u003cp\u003eAntibacterial drugs II – gram-positive organisms\u003c\/p\u003e\n\u003cp\u003eGI infections Part I \u0026amp; II\u003c\/p\u003e\n\u003cp\u003eHelicobacter and Clostridioides\u003c\/p\u003e\n\u003cp\u003eSkin and soft tissue infections\u003c\/p\u003e\n\u003cp\u003eProtozoa of clinical relevance\u003c\/p\u003e\n\u003cp\u003eWorms you should know\u003c\/p\u003e\n\u003cp\u003eDay 3 – Fungal, Mycobacterial \u0026amp; Zoonotic Diseases\u003c\/p\u003e\n\u003cp\u003eDeep mycoses (normal \u0026amp; abnormal hosts)\u003c\/p\u003e\n\u003cp\u003eNocardiosis, Actinomycosis, Rhodococcus\u003c\/p\u003e\n\u003cp\u003eTuberculosis (immunocompetent \u0026amp; immunosuppressed hosts)\u003c\/p\u003e\n\u003cp\u003eLyme disease\u003c\/p\u003e\n\u003cp\u003eTicks, mites, lice and transmitted diseases\u003c\/p\u003e\n\u003cp\u003eZoonoses\u003c\/p\u003e\n\u003cp\u003ePneumonia\u003c\/p\u003e\n\u003cp\u003eSexually transmitted infections (genital ulcers; other syndromes)\u003c\/p\u003e\n\u003cp\u003eSyndromes in the ICU relevant to ID physicians\u003c\/p\u003e\n\u003cp\u003eHospital epidemiology\u003c\/p\u003e\n\u003cp\u003eDay 4 – HIV \u0026amp; Retroviruses\u003c\/p\u003e\n\u003cp\u003eHIV diagnosis\u003c\/p\u003e\n\u003cp\u003eHIV drug resistance\u003c\/p\u003e\n\u003cp\u003eAntiretroviral therapy (general \u0026amp; special populations)\u003c\/p\u003e\n\u003cp\u003eHIV-associated opportunistic infections I \u0026amp; II\u003c\/p\u003e\n\u003cp\u003eNon–AIDS-defining complications of HIV\/AIDS\u003c\/p\u003e\n\u003cp\u003eClinical manifestations of retroviral diseases and slow viruses\u003c\/p\u003e\n\u003cp\u003eHerpes simplex\u003c\/p\u003e\n\u003cp\u003eBacterial \u0026amp; viral meningitis\u003c\/p\u003e\n\u003cp\u003ePharyngitis syndromes (including Group A strep)\u003c\/p\u003e\n\u003cp\u003eSyndromes masquerading as infections\u003c\/p\u003e\n\u003cp\u003eDay 5 – Systemic \u0026amp; Device-Related Infections\u003c\/p\u003e\n\u003cp\u003eEndocarditis (native \u0026amp; prosthetic valves, pacers, VADs)\u003c\/p\u003e\n\u003cp\u003eBone \u0026amp; joint infections\u003c\/p\u003e\n\u003cp\u003eStaphylococcus aureus infections\u003c\/p\u003e\n\u003cp\u003eNontuberculous mycobacteria (normal \u0026amp; abnormal hosts)\u003c\/p\u003e\n\u003cp\u003eInfections in solid organ recipients\u003c\/p\u003e\n\u003cp\u003eEncephalitis (including West Nile virus \u0026amp; rabies)\u003c\/p\u003e\n\u003cp\u003ePenicillin allergies\u003c\/p\u003e\n\u003cp\u003eAntifungal drugs (core concepts)\u003c\/p\u003e\n\u003cp\u003e“Kitchen sink” syndromes not covered elsewhere\u003c\/p\u003e\n\u003cp\u003eOnline-Only (OL) Bonus Lectures\u003c\/p\u003e\n\u003cp\u003eHow to prepare for certification \u0026amp; recertification (including LKA)\u003c\/p\u003e\n\u003cp\u003eBootcamp: HIV\u003c\/p\u003e\n\u003cp\u003eBootcamp: Transplant\u003c\/p\u003e\n\u003cp\u003eStatistics for the boards\u003c\/p\u003e\n\u003cp\u003eAntibacterial drugs not covered elsewhere\u003c\/p\u003e\n\u003cp\u003eTreating antimicrobial-resistant infections III\u003c\/p\u003e\n\u003cp\u003eHIV-associated opportunistic infections III\u003c\/p\u003e\n\u003cp\u003eBrain abscess, cavernous sinus thrombosis, subdural\/epidural empyema\u003c\/p\u003e\n\u003cp\u003eInfections of the urinary tract (upper \u0026amp; lower)\u003c\/p\u003e\n\u003cp\u003eEpididymitis, orchitis, prostatitis\u003c\/p\u003e\n\u003cp\u003eEven more worms\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405777850564,"sku":null,"price":156.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/George-Washington-University-Infectious-Disease-Board-Review-Course-2025.jpg?v=1784216008","url":"https:\/\/medicalcoursespro.com\/products\/george-washington-university-infectious-disease-board-review-course-2025-lecture-qbank","provider":"Medicalcoursespro","version":"1.0","type":"link"}